4.2 Article

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors

Keiichiro Kitahama et al.

Summary: This study found a higher loss rate of H3K27me3 in malignant peripheral nerve sheath tumors compared to diffuse gliomas. The loss of H3K27me3 in diffuse gliomas was significantly associated with 1p/19q codeletion, predicting 1p/19q codeletion in IDH-mutant gliomas.

BRAIN TUMOR PATHOLOGY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Clinical Neurology

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Daniel J. Brat et al.

ACTA NEUROPATHOLOGICA (2020)

Article Clinical Neurology

Mini-symposium in medulloblastoma genomics in the modern molecular era

David W. Ellison

BRAIN PATHOLOGY (2020)

Review Oncology

Overview of DNA methylation in adult diffuse gliomas

Kosuke Aoki et al.

BRAIN TUMOR PATHOLOGY (2019)

Article Clinical Neurology

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2018)

Article Oncology

Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion

Akane Yamamichi et al.

BRAIN TUMOR PATHOLOGY (2018)

Article Pathology

Immunohistochemistry on old archival paraffin blocks: is there an expiry date?

Federica Grillo et al.

JOURNAL OF CLINICAL PATHOLOGY (2017)

Article Cell Biology

Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas

Ekkehard Hewer et al.

HISTOPATHOLOGY (2016)

Article Medicine, Research & Experimental

Loss of antigenicity with tissue age in breast cancer

Susan E. Combs et al.

LABORATORY INVESTIGATION (2016)

Article Biochemistry & Molecular Biology

A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas

Yuki Fujii et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Genetics & Heredity

Mutational landscape and clonal architecture in grade II and III gliomas

Hiromichi Suzuki et al.

NATURE GENETICS (2015)

Article Oncology

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas

Heather E. Leeper et al.

ONCOTARGET (2015)